RS Investment Management (Trades, Portfolio) is a privately held San Francisco-based investment firm providing services for pension and profit sharing plans, pooled investment vehicles, corporations and banks. During the second quarter, the firm's largest buys are as follows:
The firm acquired 709,503 shares in Integra Lifesciences Holdings Corp. (IART) with an impact of 0.58% on the portfolio.
The company is engaged in the development, manufacturing and marketing of cost-effective surgical implants and medical instruments. During the second quarter, revenue increased 17.2% over the prior-year quarter and organic revenue increased 10.7%. The company reported 6.1% increase for GAAP net income.
GuruFocus gives the stock a profitability and growth rating of 5 out of 10 with ROE of 1%, which is underperforming, and ROA of 0.42%, which is outperforming 51% of the companies in the Global Medical Devices industry. Financial strength has a rating of 5 out of 10, with a cash to debt ratio of 0.12 that is below the industry median of 2.13.
Another notable shareholder among the gurus is Ken Fisher (Trades, Portfolio) with 1.35% of outstanding shares, followed by Steven Cohen (Trades, Portfolio) with 0.69%, Richard Snow (Trades, Portfolio) with 0.47% and Jim Simons (Trades, Portfolio) with 0.27%.
The firm bought 839,753 shares in Kirby Corp. (KEX) with an impact of 0.54% on the portfolio.
Kirby is a domestic tank barge operator, transporting bulk liquid products throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along all three United States coasts and in Alaska and Hawaii. Total sales increased 4.0% in the second quarter and the company recorded a $12 million LIFO charge during the second quarter, compared to a $21 million LIFO charge in the same quarter last year.
GuruFocus gives the stock a profitability and growth rating of 9 out of 10 with ROE of 8.04% and ROA of 4.43%, which are outperforming 53% of the companies in the Global Shipping & Ports industry. Financial strength has a rating of 5 out of 10, with a cash to debt ratio of 0.55 that is above the industry median of 0.45.
Diamond Hill Capital (Trades, Portfolio) is the largest shareholder of the company among the gurus, with 2.23% of outstanding shares, followed by Chuck Royce (Trades, Portfolio) with 2.16%, PRIMECAP Management (Trades, Portfolio) with 1.33%, Meridian Funds (Trades, Portfolio) with 0.79%, Steven Cohen (Trades, Portfolio) with 0.33%, Third Avenue Management (Trades, Portfolio) with 0.17% and Joel Greenblatt (Trades, Portfolio) with 0.01%.
The firm raised its stake in Ingevity Corp. (NGVT) by 2,962.66%, with an impact of 0.44% on the portfolio.
The company provides specialty chemicals and high-performance carbon materials and technologies that help customers solve complex problems. During the last quarter, adjusted EBITDA margin of 23.5% improved 130 basis points versus pro forma second quarter 2015.
GuruFocus gives the stock a profitability and growth rating of 5 out of 10 with ROE of 20.87% and ROA of 7.84%, which are outperforming 74% of the companies in the Global Specialty Chemicals industry. Financial strength has a rating of 5 out of 10, with a cash to debt ratio of 0.10 that is few below the industry median of 0.82.
The largest shareholder among the gurus is RS Investment Management (Trades, Portfolio) with 3.03% of outstanding shares, followed by Howard Marks (Trades, Portfolio) with 0.62% and T Rowe Price Equity Income Fund (Trades, Portfolio) with 0.11%.
The firm bought 694,103 shares in WebMD Health Corp. (WBMD) with an impact of 0.41% on the portfolio.
The company provides health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals and health-focused publications. Second quarter revenue grew 13% and net income increased 33%. Earnings before interest, taxes, non-cash and other items ("Adjusted EBITDA") increased 23%.
GuruFocus gives the stock a profitability and growth rating of 8 out of 10 with ROE of 44.74% and ROA of 6.05%, which are outperforming 66% of the companies in the Global Health Information Services industry. Financial strength has a rating of 4 out of 10, with a cash to debt ratio of 0.98 that is below the industry median of 11.97.
Jim Simons (Trades, Portfolio) is another notable shareholder among the gurus with 1.34% of outstanding shares, followed by Steven Cohen (Trades, Portfolio) with 0.34%, Lee Ainslie (Trades, Portfolio) with 0.12%, Joel Greenblatt (Trades, Portfolio) with 0.03% and Paul Tudor Jones (Trades, Portfolio) with 0.02%.
The firm raised his stake in Allergan PLCÂ (AGN) by 48.10%, with an impact of 0.38% on the portfolio.
The company is engaged in developing, manufacturing and distributing generic, brand and biosimilar products. Total net revenues grew 1.5% from the same quarter of a year before and 8.4% from the first quarter. Non-GAAP Diluted EPS had 8.7% year-over-year decrease but 12% quarter-on-quarter increase.
GuruFocus gives the stock a profitability and growth rating of 6 out of 10 with ROE of 5.45% and ROA of 3.23%, which are underperforming 55% of the in the Global Drug Manufacturers - Specialty & Generic industry. Financial strength has a rating of 4 out of 10, with a cash to debt ratio of 0.01 that is below the industry median of 3.15.
The largest shareholder among the gurus is Vanguard Health Care Fund (Trades, Portfolio) with 3.05% of outstanding shares, followed by Daniel Loeb (Trades, Portfolio) with 1.24%, John Paulson (Trades, Portfolio) with 1%, Carl Icahn (Trades, Portfolio) with 0.86%, Paul Singer (Trades, Portfolio) with 0.69%, Seth Klarman (Trades, Portfolio) with 0.51% and Andreas Halvorsen (Trades, Portfolio) with 0.49%.
The firm acquired 1,116,350 shares in Avis Budget Group Inc. (CAR) with an impact of 0.37% on the portfolio.
Avis provides car and truck rentals and ancillary services to businesses and consumers in North America, Europe, Australia, New Zealand and other regions.
Total revenue grew 3% in the second quarter after a 1% negative impact from currency exchange rates, driven by higher pricing in the Americas, and volume growth throughout the world. Adjusted EBITDA declined $204 million in the quarter, primarily due to higher per unit fleet costs, and the marketing-related investments we are making in our business.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 34.97%, which is outperforming, and ROA of 0.85%, which is underperforming 69% of the companies in the Global Rental & Leasing Services industry. Financial strength has a rating of 4 out of 10, with a cash to debt ratio of 0.04 that is below the industry median of 0.65.
Larry Robbins (Trades, Portfolio) is the largest shareholder of the company among the gurus, with 9.14% of outstanding shares, followed by Diamond Hill Capital (Trades, Portfolio) with 6.44%, Seth Klarman (Trades, Portfolio) with 1.97%, HOTCHKIS & WILEY with 0.62% and Jim Simons (Trades, Portfolio) with 0.15%.
The firm bought 300,500 shares in WEX Inc. (WEX) with an impact of 0.27% on the portfolio.
WEX is a provider of corporate payment solutions. It also provides funding mechanisms, among other services. Total revenue for the second quarter of 2016 increased 9.5% and net earnings attributable to WEX Inc. on a GAAP-basis decreased $13.9 million to $12.6 million.
GuruFocus gives the stock a profitability and growth rating of 7 out of 10 with ROE of 8.13%, which is outperforming, and ROA of 2.36%, which is underperforming 58% of the companies in the Global Business Services industry. Financial strength has a rating of 4 out of 10, with a cash to debt ratio of 0.27 that is below the industry median of 1.44.
The largest shareholder among the gurus is Ron Baron (Trades, Portfolio) with 1.4% of outstanding shares, followed by Mariko Gordon (Trades, Portfolio) with 1.34%, Keeley Asset Management Corp (Trades, Portfolio) with 0.68%, Steven Cohen (Trades, Portfolio) with 0.57% and Michael Dell (Trades, Portfolio) with 0.1%.
The firm bought 673,030 shares in BWX Technologies Inc. (BWXT) with an impact of 0.25% on the portfolio.
The company supplies nuclear components and fuel to the U.S. government, provides technical, management and site services, and supplies precision manufactured components and services for the commercial nuclear power industry.
GuruFocus gives the stock a profitability and growth rating of 5 out of 10 with ROE of 75.63% and ROA of 15.20%, which are outperforming 95% of the companies in the Global Aerospace & Defense industry. Financial strength has a rating of 6 out of 10, with a cash to debt ratio of 0.39 that is below the industry median of 0.40.
Jim Simons (Trades, Portfolio) is the largest shareholder of the company among the gurus, with 0.86% of outstanding shares, followed by John Hussman (Trades, Portfolio) with 0.65%, Joel Greenblatt (Trades, Portfolio) with 0.03% and Murray Stahl (Trades, Portfolio) with 0.01%.
Disclosure: I do not own any shares of any stocks mentioned in this article.
Start a free 7-day trial of Premium Membership to GuruFocus.
